RE:RE:RE:Webinar w $ATE CEO Dan Legault - Mon Nov 21 @ 4:15PM ETguilelesscat wrote: I mean it gave a lot more color. Now we know the bottleneck is with logistics, which should be cleared up in March.
Yes, 1 billion for USA sales that is correct.
All in all, it was a informative call, and worth the listen.
Who knows, maybe he's right and soon we'll be looking at a 9x or 10x jump.
otherwise...
It fails the placebo trials, and the stock craders. All we can do now is pray, and hope for good trial participants.
I'd assume that's $1B USD for post-op in the USA alone - then you have Europe, Japan and LATAM to deal.
Then we have other acute.
Then working on an IV form for the futrure.
Then you still have additional future chronic sales.
Lots of milestone opportunities.
Any issues - they can pivot - have the cash to enlist specialist ... as they've done so far.
Stock will eventually make it's move but what's more important right now ... 2 fold to 4 fold difference in dosing compared to old formulation. That seems to be the range. Impressive. No crystals ... amophous.
Boom ! Never been at a less risky point ! Like it !